Journal article · 2026 · Open access

Cross-reactive T-cell responses against BDBV in humans after rVSVΔG-ZEBOV-GP vaccination

Leonie Mayer, Rolanda Londt, Eva Gruener, My Linh Ly, Marylyn M. Addo, Christof Geldmacher

The Lancet Infectious Diseases · Published 1 October 2026 · DOI 10.1016/s1473-3099(26)00529-3

Open PDFView at the publisherCite this paper

In brief

“Cross-reactive T-cell responses against BDBV in humans after rVSVΔG-ZEBOV-GP vaccination” is a 2026 journal article by Leonie Mayer and 5 co-authors, published in The Lancet Infectious Diseases. OpenAlex counts 1 citations as of 17 November 2026, which puts it in the top 9% of works published in 2026 by citations. It is open access: the full text is free to read at medRxiv.

Citations
1
Most cited in
2026 (1)
Field-weighted impact
3.59
References
18
Authors
6

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Mayer, L., Londt, R., Gruener, E., Ly, M. L., Addo, M. M., & Geldmacher, C. (2026). Cross-reactive T-cell responses against BDBV in humans after rVSVΔG-ZEBOV-GP vaccination. The Lancet Infectious Diseases. https://doi.org/10.1016/s1473-3099(26)00529-3

MLA 9

Mayer, Leonie, et al. “Cross-reactive T-cell responses against BDBV in humans after rVSVΔG-ZEBOV-GP vaccination.” The Lancet Infectious Diseases, 2026. https://doi.org/10.1016/s1473-3099(26)00529-3.

Chicago

Mayer, Leonie, Rolanda Londt, Eva Gruener, My Linh Ly, Marylyn M. Addo, and Christof Geldmacher. 2026. “Cross-reactive T-cell responses against BDBV in humans after rVSVΔG-ZEBOV-GP vaccination.” The Lancet Infectious Diseases. https://doi.org/10.1016/s1473-3099(26)00529-3.

Harvard

Mayer, L. et al. (2026) ‘Cross-reactive T-cell responses against BDBV in humans after rVSVΔG-ZEBOV-GP vaccination’, The Lancet Infectious Diseases. doi:10.1016/s1473-3099(26)00529-3.

IEEE

L. Mayer, R. Londt, E. Gruener, M. L. Ly, M. M. Addo, and C. Geldmacher, “Cross-reactive T-cell responses against BDBV in humans after rVSVΔG-ZEBOV-GP vaccination,” The Lancet Infectious Diseases, 2026, doi: 10.1016/s1473-3099(26)00529-3.

BibTeX

@article{mayer2026cross,
  title     = {{Cross-reactive T-cell responses against BDBV in humans after rVSVΔG-ZEBOV-GP vaccination}},
  author    = {Mayer, Leonie and Londt, Rolanda and Gruener, Eva and Ly, My Linh and Addo, Marylyn M. and Geldmacher, Christof},
  journal   = {The Lancet Infectious Diseases},
  year      = {2026},
  doi       = {10.1016/s1473-3099(26)00529-3},
  url       = {https://doi.org/10.1016/s1473-3099(26)00529-3}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Topic and keywords

Health Sciences › Medicine › Infectious Diseases › Viral Infections and Outbreaks Research

  • Bundibugyo virus
  • T cell cross-reactivity
  • Ebola vaccine
  • viral vector vaccines
  • vaccine-induced immunity

Work with this paper

Most-cited papers in Medicine

All highly cited Medicine papers

Questions about this paper

How do I cite this paper in APA style?

Mayer, L., Londt, R., Gruener, E., Ly, M. L., Addo, M. M., & Geldmacher, C. (2026). Cross-reactive T-cell responses against BDBV in humans after rVSVΔG-ZEBOV-GP vaccination. The Lancet Infectious Diseases. https://doi.org/10.1016/s1473-3099(26)00529-3

How many times has this paper been cited?

1 times, according to OpenAlex on 17 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access at medRxiv: sign in and open the PDF from this page.

Who wrote this paper?

Leonie Mayer, Rolanda Londt, Eva Gruener, My Linh Ly, Marylyn M. Addo, Christof Geldmacher.

What is the DOI of this paper?

10.1016/s1473-3099(26)00529-3, permanently at https://doi.org/10.1016/s1473-3099(26)00529-3. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 17 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.